Latest return on equity
Ovid Therapeutics Return on equity
Direct answer
Ovid Therapeutics's return on equity is -25.96%.
The verified market snapshot reports -25.96%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -25.96%
Explore related company data
View Ovid Therapeutics's market capitalizationView Ovid Therapeutics's price-to-book ratioView Ovid Therapeutics's 52-week price rangeView Ovid Therapeutics's revenue growthView Ovid Therapeutics's profit marginView Ovid Therapeutics's debt-to-equity ratioView all Ovid Therapeutics key metricsReturn to Ovid Therapeutics profile